Investigating the long-term respiratory effects of 9/11 exposures on survivors
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population
This study is looking at how breathing problems in people who survived the World Trade Center disaster are connected to their exposure to the event, and it aims to help understand the different ways this has affected their lung health over time.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10903707 on NIH RePORTER |
What this research studies
This research focuses on understanding how exposure to the World Trade Center disaster has led to ongoing respiratory issues in survivors, particularly looking at both large and small airway function. By using advanced lung function tests, the study aims to identify specific patterns of airflow limitation and how these relate to the severity of exposure and other health factors. The research will also explore the differences in health impacts among various vulnerable groups within the survivor population, providing a comprehensive view of the long-term effects of this disaster on lung health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who were exposed to the World Trade Center disaster and are experiencing persistent respiratory symptoms.
Not a fit: Patients who were not exposed to the World Trade Center disaster or do not have respiratory symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for respiratory conditions in World Trade Center survivors.
How similar studies have performed: Previous research has shown significant health impacts from WTC exposures, but this study aims to provide new insights into the severe spectrum of respiratory disease, making it a novel investigation.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Liu, Mengling — New York University School of Medicine
- Study coordinator: Liu, Mengling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.